论文部分内容阅读
目的:对喜炎平与多索茶碱治疗小儿毛细支气管炎疗效和安全性进行观察与探讨。方法:对我院接受治疗的80例毛细支气管炎患儿进行临床的相关研究,按照随机的原则分为2组,分析两组毛细支气管炎患儿的效果。结果:研究组患儿的治疗总有效率(95.0%)明显的高于对照组患儿(72.5%),组间差异明显(P<0.05),且研究组患儿的不良反应发生率(17.5%)明显低于对照组患儿(5.0%),差异显著(P<0.05)。结论:与喜炎平治疗相比,多索茶碱用于治疗小儿毛细支气管炎的效果更佳,不良反应更少。
Objective: To observe and discuss the efficacy and safety of Xiyanping and doxofylline in the treatment of children with bronchiolitis. Methods: Eighty patients with bronchiolitis treated in our hospital were studied clinically. According to the principle of randomization, they were divided into two groups to analyze the effect of two groups of patients with bronchiolitis. Results: The total effective rate (95.0%) in study group was significantly higher than that in control group (72.5%) (P <0.05), and the incidence of adverse reactions in study group was 17.5 %) Was significantly lower than the control group (5.0%), the difference was significant (P <0.05). CONCLUSION: Doxofylline is more effective in treating children with bronchiolitis compared with Xiyanping treatment, with fewer side effects.